8. Emerging Trends on Social Media
- Trends on Twitter
- Popular Keywords and Word Cloud Analysis
9. Recent Trends in 3D Bioprinting Industry
- Introduction of Scaffold-Free Bioprinting
- Emergence of 4D Bioprinting: the Next Generation of 3D Bioprinting
- Use of Stem Cells as Bio Ink
- Development of UV 3D Bioprinting, a Modified Stereolithography Approach
- Establishment of Spin-Offs of Academic Institutes
- Entry of Well-Established Players of 3D Printing Industry in Bioprinting Industry
- Introduction of Low-Priced Bioprinters
- Increasing Number of Initiatives Taken by Governments of Different Countries
10. Product Competitiveness Analysis
- 3D Bioprinters: 2 x 2 Product Competitiveness vs. Supplier Power Analysis
11. Patent Analysis
- 3D Bioprinting Patents: Distribution by Publication Year
- 3D Bioprinting Patents: Distribution by Geographical Location
- 3D Bioprinting Patents: Distribution by CPC Classifications
- 3D Bioprinting Patents: Emerging Areas
- 3D Bioprinting Patents: Leading Players
12. Market Forecast and Opportunity Analysis
- Forecast Methodology
- Overall 3D Bioprinting Market, 2018-2035
- 3D Bioprinting Market: Distribution by Applications
- 3D Bioprinting Market: Distribution by Region (North America, Europe, Asia Pacific and Rest of the World)
- 3D Bioprinting Market: Distribution by Technology (Extrusion, Inkjet, Laser and Others)
13. Conclusion
- 3D Bioprinting has Garnered Significant Attention within the Biopharmaceutical Industry
- The Competitive Market Landscape Features a Mix of Industry and Non-Industry Players
- North America and Europe Dominate the Current Market; Several Companies based in the Asia Pacific are also Making Notable Progress
- Research Continues to be the Major Focus as Stakeholders Strive to Improve Existing Methods and Technologies
- Increasing Partnership Activity and Financial Support from Public and Private Investors are Expected to Drive Growth
- Recent Advances are Expected to Act as Catalyst to the Success of 3D Bioprinting
- Inherent Challenges Must be Overcome to Tap the Multi-billion Dollar Opportunity in the Long Term
14. Interview Transcripts
- Douglas Chrisey, Professor, Tulane University
- Igor Zlatkin, Application Scientist and Chirantan Kanani, Technology & Product Development, Digilab
- Fanny Geraldo and Lisa Oliver, Researchers, University of Nantes
- Glauco R Souza, President & Chief Scientific Officer and Hubert Tseng, Senior Research Scientist, n3D Biosciences
- Kenneth Church, President & Chief Executive Officer and Xudong Chen, Executive Vice President Business Development & Sales, nScrypt
- Laura Bosworth, Chief Executive Officer & Co-Founder, TeVido BioDevices
- Lauralyn McDaniel, Industrial Manager, SME
- Marc Thurner, Chief Executive Officer, regenHU
- Roger Narayan, Professor, North Carolina State University
- Simon Fried, Chief Business Officer, Nano Dimension
- Anonymous, MicroFab Technologies
